首页 > 文献资料库 > 详情

艾维岚® 在1例修饰先天前额骨性发育不全患者中的效果

胡慧贞,医学美学美容 2022年11月

胡慧贞 (湖州吴兴曙光威兹曼医疗美容门诊部注射科,浙江 湖州 313000) 

【摘 要】

目的 观察1例艾维岚® 在修饰先天前额骨性发育不全患者中的应用效果。

方法 选取2021年3月因 先天前额骨性发育不全而导致真皮萎缩于我院就诊的1例患者为研究对象,选用艾维岚® 进行为期2个月的 额部注射治疗。观察临床疗效、不良反应发生情况、患者满意度。

结果 患者前额不平整状态得到矫正,凹凸不平现象得到缓解,额部轮廓自然,线条流畅,无明显不良反应,患者对治疗效果非常满意。

结论 艾维岚® 额部注射用于纠正先天性前额骨性发育不全效果良好,能够有效改善面部额骨不平整现象,且具有微创、安全、有效、并发症较少的优点,值得应用。 

【关键词】额部注射填充术;额部轮廓重塑;聚左旋乳酸;整形美容 

中图分类号:R782.2 文献标识码:A 文章编号:1004-4949(2022)22-0009-03

第一作者:胡慧贞(1984.12-),女,浙江衢州人,本科,主治医师,主要从事注射填充的年轻化抗衰治疗工作 

引用格式:胡慧贞.艾维岚® 在1例修饰先天前额骨性发育不全患者中的效果[J].医学美学美容,2022,31(22):9-11



你可能喜欢...

08-12

2021

A Decade of Experience with Injectable Poly-L-Lactic Acid: A Focus on Safety

Important lessons have been learned in the use of injectable PLLA that have helped reduce the frequency of adverse events and make it desirable for restoring facial volume (Table 1). The importance of diffuse distribution of the injectable PLLA suspension

09-22

2021

Advanced injection techniques of poly-L-lactic acid: a case-based presentation

This article presents a patient who illustrates the current treatment techniques that optimize the efficacy and tolerability of poly-L-lactic acid.

09-22

2021

Consensus Recommendations on the Use of Injectable Poly-L-Lactic Acid for Facial and Nonfacial Volum

Poly-L-lactic acid (PLLA) was approved for use in Europe in 1999. In the United States, it was approved by the Food and Drug Administration in 2004 for the treatment of facial lipoatrophy associated with human immunodeficiency virus, and in 2009 for cosm